An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT00542633 · COMPLETED
Trial details
- NCT number
- NCT00542633
- Sponsor
- Biodel
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-08-01
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.